Luigi Trussardo
CEO of Olon Ricerca Bioscience

Click HERE to download the PDF version

Once upon a time…is the typical starting of a traditional narration, but for today let’s have our beginning from the latest news: on June 8th Olon SpA announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA.
Olon Ricerca Bioscience (ORB)is a CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Ricerca’s extensive process/synthetic chemistry, analytical chemistry and Engineering expertise provides a synergy that excels at first‐time scale‐ups and subsequent Development of safe, reliable, robust and cost effective manufacturing processes.
This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech Industry and benefits the Olon Ricerca Bioscience customer base by providing large scale manufacturing capabilities in Europe with 8 FDA-inspected manufacturing plants.
Olon has decided to consolid ...